宫颈低级别鳞状上皮内病变合并高危型HPV感染治疗进展
Progress in the Treatment of Cervical Low-Grade Squamous Intraepithelial Lesion Combined with High-Risk HPV Infection
摘要: 宫颈癌(Cervical Cancer)是我国最常见的妇科肿瘤,目前认为宫颈癌的发生发展,是因为宫颈上皮内病变继续发展,突破上皮下基底膜,浸润间质,形成了宫颈浸润癌。宫颈低级别鳞状上皮内病变大部分患者可以自然消退,在极少数个体中,长期的高危型HPV感染可能促使宫颈发展至高级别鳞状上皮内病变,并有可能最终演变为宫颈癌。针对合并高危型HPV感染的宫颈低级别鳞状上皮内病变,当前的治疗方案包括药物治疗、物理疗法和手术切除等多种方法。临床可根据患者年龄、生育诉求及实际病情和经济状况,选择合适的治疗方案。本文对宫颈低级别鳞状上皮内病变合并高危型HPV感染的治疗策略进行综述,对于临床指导实践具有重要意义。
Abstract: Cervical cancer is the most common gynecological tumor in our country. It is currently believed that the occurrence and development of cervical cancer are a process where cervical intraepithelial neoplasia progresses, breaks through the basement membrane under the epithelium, infiltrates the stroma, and forms invasive cervical cancer. Most patients with low-grade squamous intraepithelial lesions (LSIL) of the cervix can naturally regress. In a very small number of individuals, long-term high-risk HPV infection may promote the progression of the cervix to high-grade squamous intraepithelial lesions (HSIL) and potentially evolve into cervical cancer. For low-grade squamous intraepithelial lesions of the cervix associated with high-risk HPV infection, current treatment options include drug therapy, physical therapy, and surgical excision, among various methods. Clinically, appropriate treatment plans can be selected based on the patient’s age, fertility desires, actual condition, and economic status. This article reviews the treatment strategies for low-grade squamous intraepithelial lesions of the cervix combined with high-risk HPV infection, which is of significant importance for guiding clinical practice.
文章引用:李彩云, 罗光霞, 罗雪梅. 宫颈低级别鳞状上皮内病变合并高危型HPV感染治疗进展[J]. 临床医学进展, 2025, 15(1): 1506-1511. https://doi.org/10.12677/acm.2025.151201

参考文献

[1] Burmeister, C.A., Khan, S.F., Schäfer, G., Mbatani, N., Adams, T., Moodley, J., et al. (2022) Cervical Cancer Therapies: Current Challenges and Future Perspectives. Tumour Virus Research, 13, Article ID: 200238. [Google Scholar] [CrossRef] [PubMed]
[2] Buskwofie, A., David-West, G. and Clare, C.A. (2020) A Review of Cervical Cancer: Incidence and Disparities. Journal of the National Medical Association, 112, 229-232. [Google Scholar] [CrossRef] [PubMed]
[3] Saraiya, M., Unger, E.R., Thompson, T.D., Lynch, C.F., Hernandez, B.Y., Lyu, C.W., et al. (2015) US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines. JNCI: Journal of the National Cancer Institute, 107, djv086. [Google Scholar] [CrossRef] [PubMed]
[4] 魏丽惠, 沈丹华, 赵方辉, 等. 中国子宫颈癌筛查及异常管理相关问题专家共识(二) [J]. 中国妇产科临床杂志, 2017, 18(3): 286-288.
[5] 毕蕙, 李明珠, 赵超, 等. 子宫颈低级别鳞状上皮内病变管理的中国专家共识[J]. 中国妇产科临床杂志, 2022, 23(4): 443-445.
[6] Perkins, R.B., Guido, R.S., Castle, P.E., Chelmow, D., Einstein, M.H., Garcia, F., et al. (2024) 2019 ASCCP Risk-Based Management Consensus Guidelines: Updates through 2023. Journal of Lower Genital Tract Disease, 28, 3-6. [Google Scholar] [CrossRef] [PubMed]
[7] Liu, M., Yan, X., Zhang, M., Li, X., Li, S. and Jing, M. (2017) Influence of Human Papillomavirus Infection on the Natural History of Cervical Intraepithelial Neoplasia 1: A Meta-Analysis. BioMed Research International, 2017, Article ID: 8971059. [Google Scholar] [CrossRef] [PubMed]
[8] 李明珠, 赵昀, 李静然, 等. 2019 ASCCP基于风险的子宫颈癌筛查结果异常的管理共识解读[J]. 中国妇产科临床杂志, 2020, 21(4): 446-448.
[9] 覃小敏, 邢辉, 李琳, 等. 高危型HPV持续感染在宫颈病变中的分布及其影响因素分析[J]. 癌症进展, 2017, 15(12): 1439-1442.
[10] 何福姬. 重组人干扰素α-2b凝胶联合保妇康栓治疗宫颈高危型HPV感染的临床分析[J]. 中国实用医药, 2023, 18(11): 123-126.
[11] Gross, G.E., Werner, R.N., Becker, J.C., Brockmeyer, N.H., Esser, S., Hampl, M., et al. (2018) S2k Guideline: HPV‐Associated Lesions of the External Genital Region and the Anus—Anogenital Warts and Precancerous Lesions of the Vulva, the Penis, and the Peri‐ and Intra‐Anal Skin (Short Version). JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 16, 242-255. [Google Scholar] [CrossRef] [PubMed]
[12] 陈锐, 赵健, 廖秦平. 派特灵治疗宫颈上皮内瘤变1、2级临床疗效观察[J]. 中国实用妇科与产科杂志, 2011, 27(9): 703-705.
[13] 常琦, 张玲. 中药制剂派特灵应用于宫颈高危人乳头瘤病毒(HPV)感染的临床疗效研究[J]. 药物生物技术, 2021, 28(5): 505-508.
[14] 舒爱明, 付志红, 周琼. 派特灵治疗宫颈糜烂40例临床观察[J]. 实用中西医结合临床, 2012, 12(5): 42-43.
[15] 姚心雨, 郑子雯, 李凌, 等. 复方中药外用制剂派特灵治疗高危型HPV持续感染宫颈病变的临床疗效[J]. 实用癌症杂志, 2019, 34(12): 2053-2054.
[16] 刘莲慧, 秦文敏, 张莹雪, 等. 派特灵治疗高危型人乳头瘤病毒(HR-HPV)感染疗效的Meta分析[J]. 中草药, 2021, 52(22): 6928-6938.
[17] 温美珠. 干扰素联合瑞贝生治疗宫颈高危型HPV持续感染患者的疗效及对其免疫水平的影响[J]. 中国现代药物应用, 2024, 18(20): 90-93.
[18] 于江华, 尚志杰, 洪丽仁, 等. 瑞贝生在宫颈高危型人乳头瘤病毒持续感染中的疗效分析[J]. 中国现代药物应用, 2021, 15(22): 173-175.
[19] Zhou, Y. (2011) High Intensity Focused Ultrasound in Clinical Tumor Ablation. World Journal of Clinical Oncology, 2, 8-27. [Google Scholar] [CrossRef] [PubMed]
[20] Al-Bataineh, O., Jenne, J. and Huber, P. (2012) Clinical and Future Applications of High Intensity Focused Ultrasound in Cancer. Cancer Treatment Reviews, 38, 346-353. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, W., Yao, Y., Liu, Y., Ren, J., Chen, L., Wang, Z., et al. (2022) Focused Ultrasound for High-Risk Human Papillomavirus Infection-Related Low-Grade Cervical Lesions: A Prospective Cohort Study. International Journal of Hyperthermia, 39, 1327-1334. [Google Scholar] [CrossRef] [PubMed]
[22] 邱丽华, 李静然, 陈飞, 等. 氨基酮戊酸光动力疗法在女性下生殖道疾病的临床应用专家共识[J]. 中国妇产科临床杂志, 2022, 23(4): 446-448.
[23] 蒋捷, 邹健, 朱杏楣, 等. 光动力诊疗中的5-氨基酮戊酸及酯类衍生物的研究进展[J]. 激光生物学报, 2019, 28(4): 289-295.
[24] Maździarz, A. (2019) Successful Pregnancy and Delivery Following Selective Use of Photodynamic Therapy in Treatment of Cervix and Vulvar Diseases. Photodiagnosis and Photodynamic Therapy, 28, 65-68. [Google Scholar] [CrossRef] [PubMed]
[25] 蔡微, 郑礼宝, 黄剑清, 等. 5-氨基酮戊酸光动力治疗宫颈高危型HPV病毒持续性感染的疗效观察[J]. 皮肤病与性病, 2018, 40(5): 678-680.
[26] Wang, H.R., Lin, Y., Zhang, X.Y., et al. (2018) Transvaginal Color Doppler Sonography Combined with Colposcopy for Diagnosis of Early Stage Cervical Cancer and Precancerous Lesions. Journal of Biological Regulators and Homeostatic Agents, 32, 123-126.
[27] 陈见美, 符永帅, 周冬梅, 等. 宫颈冷刀锥切术治疗宫颈上皮内瘤变的疗效观察及术后切缘阳性的危险因素分析[J]. 现代生物医学进展, 2020, 20(1): 135-139.
[28] 谭燕波. 宫颈环形电切术治疗宫颈癌前病变的临床疗效及并发症发生率研究[J]. 吉林医学, 2020, 41(2): 378-379.
[29] 蒋玉琴. LEEP、冷刀宫颈锥切术治疗宫颈上皮内瘤变疗效对比分析[J]. 实用妇科内分泌电子杂志, 2019, 6(34): 34+9.